ストックスクリーナーアプリを入手
36.84
3.59%
-1.37
前日終値:
$38.21
開ける：
$38.44
24時間の取引高:
668.82K
Relative Volume:
0.81
時価総額：
$2.13B
収益：
$899.11M
当期純損益:
$145.62M
株価収益率:
14.84
EPS:
2.4829
ネットキャッシュフロー:
$322.54M
1週間 パフォーマンス:
-1.13%
1か月 パフォーマンス:
+3.83%
6か月 パフォーマンス:
-4.44%
1年 パフォーマンス:
+7.31%
1日の値動き範囲:
$36.17
$38.50
1週間の範囲:
$36.17
$38.89
52週間の値動き範囲:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
36.84 | 2.13B | 899.11M | 145.62M | 322.54M | 2.4829 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2026-02-23 | ダウングレード | Truist | Buy → Hold |
| 2026-02-11 | 再開されました | UBS | Neutral |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Enterprise value to EBITDA forward of Harmony Biosciences Holdings, Inc. – NASDAQ:HRMY - TradingView
Mizuho reiterates Harmony Biosciences stock rating on patent case - Investing.com
Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
HRMY growth trends beyond Wakix could shape its next growth phase - MSN
Price to sales forward of Harmony Biosciences Holdings, Inc. – NASDAQ:HRMY - TradingView
Is HRMY stock worth buying with neutral signals and cheap valuation? - MSN
HRMYHarmony Biosciences Holdings Inc Latest SEC Filings - Finviz
HRMY.O - Reuters
Harmony Biosciences holds steady as investors await the next catalyst. - ad-hoc-news.de
Top 5 US Stocks To Buy In July 2026 - Investing.com
25,000-share option exercise; affiliate sales reported — HRMY - Stock Titan
Form 144 HARMONY BIOSCIENCES HOLDINGS For: 30 June By Investing.com - Investing.com Nigeria
Sandip Kapadia reports sale activity (HRMY) via Form 144 totaling 50,000 - Stock Titan
HRMY Maintained by Deutsche Bank -- Price Target Raised to $36 - GuruFocus
Deutsche Bank Adjusts Price Target on Harmony Biosciences to $36 From $30, Maintains Hold Rating - marketscreener.com
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? - TradingView
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline - Yahoo Finance
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase - Zacks Investment Research
HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits
Form 144 HARMONY BIOSCIENCES HOLDINGS For: 26 June By Investing.com - Investing.com South Africa
Harmony Biosciences (HRMY) Surges 3.93% as Positive Momentum BuildsMACD Signal Stocks - dars.gov.et
Harmony Biosciences Holdings Inc (HRMY) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
HRMY News | HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) - ChartMill
Form 144 HARMONY BIOSCIENCES HOLDINGS For: 26 June - Investing.com India
The Technical Signals Behind (HRMY) That Institutions Follow - Stock Traders Daily
HRMY affiliate gives notice to sell 45,594 shares (NASDAQ: HRMY) - Stock Titan
Harmony Biosciences Holdings, Inc. Actuals & Estimates (NASDAQ:HRMY) - TradingView
Harmony Biosciences Holdings, Inc. Actuals & Estimates (SWB:60H) - TradingView
HRMY Forecast — Price Target — Prediction for 2027 - TradingView
Form 144 HARMONY BIOSCIENCES HOLDINGS For: 24 June By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Harmony Biosciences stock rating at buy - Investing.com UK
Sandip Kapadia (HRMY) files Rule 144 notice, Morgan Stanley as broker - Stock Titan
H.C. Wainwright reiterates Harmony Biosciences stock rating at buy By Investing.com - Investing.com Australia
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Harmony Biosciences Holdings Inc (HRMY) Institutional Confidence - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Harmony Biosciences StockAnalyst consensus and technical backdrop - AD HOC NEWS
Harmony Biosciences (HRMY) Slips on Low Volume, Hovers Near Key SupportCorrective Wave - dars.gov.et
Harmony Biosciences Holdings Inc (HRMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Harmony Biosciences Holdings Inc - TradingKey
Precision Trading with Harmony Biosciences Holdings Inc. (HRMY) Risk Zones - Stock Traders Daily
Wall Street analysts think Harmony Biosciences (HRMY) could surge 34.81%: Read this before placing a bet - MSN
Harmony Biosciences (HRMY) Stock Valuation After New Pitolisant Data And Reaffirmed Guidance - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):